SenolyticEmerging
Fisetin
Flavonoid with senolytic activity in animal models. Clinical endpoints in humans still unclear.
Goals
Longevity (broad)
Timing
Pulse dosed
Price tier
Premium
Dosage
Study protocols: 20 mg/kg on 2 consecutive days per month. Liposomal form preferred for bioavailability.
Considerations
Mayo Clinic trials ongoing. Until then: experimental, not standard practice.
Form
Capsule
Scientific detail
Senolytische ClearanceAnti-InflammatorischPI3K/AKT-Inhibition
Cellular senescenceChronic inflammation
Evidence base